Contractile effects of 5-hydroxytryptamine (5-HT) in the equine jejunum circular muscle: Functional and immunohistochemical identification of a 5-HT1A-like receptor

Equine Veterinary Journal

Volumn 40, Issue 4, 2008, Pages 313-320

  Delesalle, C ^a   Van Acker, N ^b   Claes, P ^b   Deprez, P ^a   De Smet, I ^a   Dewulf, J ^a   Lefebvre, R A ^c  

^a GHENT UNIVERSITY   (Belgium)

^b HistoGeneX NV   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Colic; Horse; Ileus; Serotonin; Small intestine

Indexed keywords

SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT;

ANIMAL; ANIMAL DISEASE; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; FEMALE; HORSE; HORSE DISEASE; ILEUS; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; JEJUNUM; MALE; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY; PHYSIOLOGY; SMOOTH MUSCLE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HORSE DISEASES; HORSES; ILEUS; IMMUNOHISTOCHEMISTRY; JEJUNUM; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN AGENTS;

EQUIDAE; ORYCTOLAGUS CUNICULUS;

EID: 45849104557     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516408X278193     Document Type: Conference Paper

References (37)

1. Ahlers, S.T., Weissman, B.A. and Barrett, J.E. (1992) Antagonism studies with BMY-7378 and NAN 190 - effects on 8-hydroxy-2-(di-normal-propylamino) tetralin-induced increases in punished responding of pigeons. J. Pharmacol. Expt. Ther. 260, 474-481.
2. Bailey, S.R., Menzies-Gow, N.J., Marr, C.M. and Elliott, J. (2004) The effects of vasoactive amines found in the equine hindgut on digital blood flow in the normal horse. Equine vet. J. 36, 267-272.
3. Briejer, M.R., Akkermans, L.M.A., Meulemans, A.L., Lefebvre, R.A. and Schuurkes, J.A.J. (1992) Nitric oxide is involved in 5-HT-induced relaxations of the guinea-pig colon ascendens in vitro. Br. J. Pharmacol. 107, 756-761.
4. Buchheit, K.H. and Buhl, T. (1994) Stimulant effects of 5-hydroxytryptamine on guinea-pig stomach preparations in-vitro. Eur. J. Pharmacol. 262, 91-97.
5. Cao, B.J. and Rodgers, R.J. (1997) Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190. Pharmacol. Biochem. Behav. 58, 593-603.
6. Chanda, P.K., Minchin, M.C., Davis, A.R., Greenberg, L. and Reilly, Y. (1993) Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor. J. expt. Pharmacol. Ther. 43, 516-520.
7. Corleto, V.D., Severi, C., Romano, G., Tattoli, I., Weber, H.C., Stridsberg, M., Rindi, G., Campanini, N., Tomassoni, F., Pagotto, U., Coy, D.H., Jensen, R.T. and Delle Fave, G. (2006) Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells. Neurogastroenterol. Motil. 18, 217-225.
8. Delco, M., Nieto, J., Craigmill, A.L., Stanley, S.D. and Snyder, J.R. (2007) Pharmacokinetics and in vitro effects of tegaserod, a serotonin 5-hydroxytryptamine 4 (5-HT4) receptor agonist with prokinetic activity in horses. Vet. Therapeut. 8, 77-87.
9. Delesalle, C., Deprez, P., Schuurkes, J.A.J. and Lefebvre, R.A. (2006) Contractile effects of 5-hydroxytryptamine and 5-carboxamidotryptamine in the equine jejunum. Br. J. Pharmacol. 147, 23-35.
10. El Yazbi, A.F., Schulz, R. and Daniel, E.E. (2007) Differential inhibitory control of circular and longitudinal smooth muscle layers of Balb/C mouse small intestine. Autonom. Neurosci. Basic Clin. 131, 36-44.
11. Gershon, M.D. and Tack, J. (2007). The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterol. 132, 397-414.
12. Grider, J.R. (1998) Reciprocal activity of longitudinal and circular muscle during intestinal peristaltic reflex. Am. J. Physiol. gastrointest. Liver. Physiol. 284, 768-775.
13. Hagan, J.J., Price, G.W., Jeffrey, P., Deeks, N.J., Stean, T., Piper, D., Smith, M.I., Upton, N., Medhurst, A.D., Middlemiss, D.N., Riley, G.J., Lovell, P.J., Bromidge, S.M. and Thomas, D.R. (2000) Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist. Br. J. Pharmacol. 130, 539-548.
14. Hoyer, D., Clarke, D.E., Fozard, J.R., Hartig, P.R., Martin, G.R., Mylecharane, E.J., Saxena, P.R. and Humphrey, P.P.A. (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46, 157-203.
15. Ho, B.Y., Karschin, A., Branchek, T., Davidson, N. and Lester, H.A. (1992) The role of conserved aspartate and serine residues in ligand binding and in function of the 5-HT1Areceptor: a site-directed mutagenesis study. FEBS Lett. 312, 259-262.
16. Janssen, P., Prins, N.H., Peeters, P.J., Zuideveld, K.P. and Lefebvre, R.A. (2004) 5-HT7 receptor efficacy distribution throughout the canine stomach. Br. J. Pharmacol. 143, 331-342.
17. 2 receptor. Eur. J. Pharmacol. 239, 111-118.
18. 3H)WAY-100635, a novel 5-hydroxytryptamine1A receptor antagonist, to rat brain. J. Neorochem. 64, 2716-2726.
19. Koehne, E. (2000) Dünn-und Dickdarmmotilität des Pferdes. Disse: Tierärztliche Hocgschule, Hannover. 111-114.
20. Lepard, K.J. and Galligan, J.J. (2004) Presynaptic modulation of cholinergic and noncholinergic fast synaptic transmission in the myenteric plexus of guinea pig ileum. Neurogastroenterol. Motil. 16, 355-364.
21. Menzies-Gow, N.J., Bailey, S.R., Katz, L.C., Marr, C.M. and Elliott, J. (2004) Endotoxin-induced digital vasoconstriction in horses: associated changes in plasma concentrations of vasoconstrictor mediators. Equine vet. J. 36, 273-278.
22. Meulemans, A.L., Helsen, L.F. and Schuurkes, J.A.J. (1993) The role of nitric oxide (NO) in 5-HT-induced relaxations of the guinea-pig stomach. Naunyn-Schmiedebergh's Arch. Pharmacol. 348, 424-430.
23. Moller, M., Cumming, P., Andersen, G. and Gjedde, A. (2004) Parametric mapping of serotonin 5HT1A receptors in healthy human brain. Neuroimage. 22, T157-T157.
24. Momozawa, Y., Takeuchi Y., Tozaki, T., Kikusui, T., Hasegawa, T., Raudsepp, T., Chowdhary, B.P., Kusunose, R. and Mori, Y. (2006) SNP detection and radiation hybrid mapping in horses of nine candidate genes for temperament. Anim. Genet. 38, 81-91.
25. 5 receptors. Curr. Drug Targets CNS Neurol. Disord. 3, 53-58.
26. Nieto, J.E., Snyder, J.R., Kollias-Baker, C. and Stanley, S. (2000) In vitro effects of 5-hydroxytryptamine and cisapride on the circular smooth muscle of the jejunum of horses. Am. J. vet. Res. 61, 1561-1565.
27. 1A receptor expression in the developing hippocampus. Brain. Res. Dev. Brain. Res. 9, 42-57.
28. Pazos, A. and Palacios, J.M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. Brain Res. 346, 205-230.
29. Rakestraw, P.C., Snyder, J.R., Woliner, M.J., Sanders, K.M. and Shuttleworth, W.R. (1996) Involvement of nitric oxide in inhibitory neuromuscular transmission in equine jejunum. Am. J. vet. Res. 57, 1206-1213.
30. 1A receptor: G protein coupling and signalling pathways. Br. J. Pharmacol. 127, 1751-1764.
31. Saigal, N., Pichika, R., Easwaramoorthy, B., Collins, D., Christian, B.T., Shi, B., Narayanan, T.K., Potkin, S.G. and Mukherjee, J. (2006) Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. J. nucl. Med. 47, 1697-1706.
32. 2 receptor antagonism by BRL 43694 (granisetron). Eur. J. Pharmacol. 159, 113-124.
33. 1A receptor antagonist. Eur. J. Pharmacol. 244, 251-257.
34. 1-like receptor mediating contraction in the canine coronary artery. Eur. J. Pharmacol. 300, 109-112.
35. 7 receptors. Curr. Drug Targets CNS Neurol. Disord. 3, 81-90.
36. Vatistas, N.J., Nieto, J.E., Van Hoogmoed, L., Gardner, I. and Snyder, J.R. (2003) Use of an isolated intestinal circuit to evaluate the effect of ischemia and reperfusion on mucosal permeability of the equine jejunum. Vet. Surg. 32, 52-61.
37. Weiss, R., Abel, D., Scholtysik, G., Straub, R. and Mevissen, M. (2002) 5-hydroxytryptamine mediated contractions in isolated preparations of equine ileum and pelvic flexure: pharmacological characterization of a new 5-HT4 agonist. J. vet. Pharmacol. Ther. 25, 49-58.